Insulinoma
View article: Diagnosis of Neuroendocrine Tumor of the Pancreas by External Ultrasound-Fine Needle Aspiration Cytology Sampling: Case Report and a Brief Review of the Literature
Diagnosis of Neuroendocrine Tumor of the Pancreas by External Ultrasound-Fine Needle Aspiration Cytology Sampling: Case Report and a Brief Review of the Literature Open
Pancreatic neuroendocrine tumors (PanNETs) are uncommon pancreatic neoplasms that develop from islet cells. The existing method of preoperative tissue diagnosis and grading is ultrasound-guided fine-needle aspiration of the mass. We presen…
View article: Figure S1 from Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma
Figure S1 from Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma Open
updated figure S1
View article: Figure S3 from Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma
Figure S3 from Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma Open
Figure S3
View article: Figure 3 from The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis
Figure 3 from The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis Open
Forest plots from random-effects meta-analysis of the association between nutrition-related biomarkers and PDAC risk. A, Pyridoxal 5′-phosphate (PLP) and (B) 25-hydroxyvitamin D [25-(OH)-D].
View article: Figure 2 from The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis
Figure 2 from The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis Open
Forest plots from random-effects meta-analysis of the association between glucose metabolism–related biomarkers and PDAC risk. A, Glucose; B, IGF-1; C, IGFBP-3; D, IGF-1/IGFBP-3 molar ratio; E, C-peptide.
View article: Figure 5 from The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis
Figure 5 from The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis Open
Forest plots from random-effects meta-analysis of the association between inflammation-related biomarkers and PDAC risk. A, Adiponectin and (B) C-reactive protein.
View article: Figure S2 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
Figure S2 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression Open
Representative tandem MS spectrum of the QATGIEDGELR peptide from CUL4B as determined by IP-Mass Spec
View article: Table S2 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
Table S2 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression Open
Clinicopathologic parameters of 50 PanNET patients
View article: Table S3 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
Table S3 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression Open
Gene mutation analysis identified in 50 patients with PanNETs
View article: Table S4 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
Table S4 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression Open
No difference in DCAF7 expression levels in MEN1 wildtype vs mutant samples
View article: Figure S1 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
Figure S1 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression Open
Representative tandem MS spectrum of the LPENYTDETWQK peptide from CUL4B as determined by IP-Mass Spec
View article: Incidental 68Ga -DOTATATE Uptake in Metastatic Clear Cell Renal Cell Carcinoma: A Case Report
Incidental 68Ga -DOTATATE Uptake in Metastatic Clear Cell Renal Cell Carcinoma: A Case Report Open
68Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) is a more accurate way to distinguish neuroendocrine tumors compared with conventional diagnostic methods and a standard impressive way to evaluate disease entities. T…
View article: EVALUATION OF PANCREATIC TUMOR ON CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND ITS CORRELATION WITH LAB TEST CA19-9
EVALUATION OF PANCREATIC TUMOR ON CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND ITS CORRELATION WITH LAB TEST CA19-9 Open
View article: EVALUATION OF PANCREATIC TUMOR ON CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND ITS CORRELATION WITH LAB TEST CA19-9
EVALUATION OF PANCREATIC TUMOR ON CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND ITS CORRELATION WITH LAB TEST CA19-9 Open
View article: EVALUATION OF PANCREATIC TUMOR ON CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND ITS CORRELATION WITH LAB TEST CA19-9
EVALUATION OF PANCREATIC TUMOR ON CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND ITS CORRELATION WITH LAB TEST CA19-9 Open
View article: EVALUATION OF PANCREATIC TUMOR ON CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND ITS CORRELATION WITH LAB TEST CA19-9
EVALUATION OF PANCREATIC TUMOR ON CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND ITS CORRELATION WITH LAB TEST CA19-9 Open
View article: EVALUATION OF PANCREATIC TUMOR ON CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND ITS CORRELATION WITH LAB TEST CA19-9
EVALUATION OF PANCREATIC TUMOR ON CONTRAST ENHANCED COMPUTED TOMOGRAPHY AND ITS CORRELATION WITH LAB TEST CA19-9 Open
View article: Laparoscopic central pancreatectomy for solid pseudopapillary neoplasm: A case report
Laparoscopic central pancreatectomy for solid pseudopapillary neoplasm: A case report Open
Background: Solid pseudopapilaty neoplasm (SPN) is a rare exocrine pancreatic tumor mostly found in young women, and a low malignant potential lesion. Laparoscopic central pancreatectomy for this tumor of the pancreatic body prevent from p…
View article: Annular pancreas
Annular pancreas Open
View article: Trombo tumoral intracardiaco: reporte de cuatro casos pediátricos y revisión de la literatura
Trombo tumoral intracardiaco: reporte de cuatro casos pediátricos y revisión de la literatura Open
View article: Case Report: ACTH- and CRH-secreting pheochromocytoma as a very rare cause of ectopic Cushing syndrome
Case Report: ACTH- and CRH-secreting pheochromocytoma as a very rare cause of ectopic Cushing syndrome Open
Ectopic adrenocorticotropic hormone (ACTH) syndrome (EAS) represents a rare clinical entity characterized by severe hypercortisolemia. Pheochromocytoma, a neuroendocrine neoplasm originating from chromaffin cells within the adrenal medulla…
View article: Pancreatic arteriovenous malformation: An incidental finding
Pancreatic arteriovenous malformation: An incidental finding Open
View article: Figure S2 from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment
Figure S2 from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment Open
Figure S2. Tissue immunohistochemistry of K-rasLSL.G12D/+; Trp53R172H/+; Pdx-1-Cre (KPC) tissue carrying a spectrum of pancreatic disease. H&E (left) and ZIP3 (right) IHC of KPC tissue bearing A) PanIN (II-III) and large tumor, and KPC wit…
View article: Figure S5 from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment
Figure S5 from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment Open
Figure S5. MRI of unstimulated animals on MRTX1133 treatment and after MRTX1133 treatment withdrawal. (Left) Quantified dynamic change in CNR of tumor-bearing pancreas tissue vs. muscle over time. (Right) Area under the change in CNR over …
View article: Figure S6 from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment
Figure S6 from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment Open
Figure S6. SSZS as treatment during tumor progression. A) 10,000 PDAC Hy14459 cells were implanted into the mouse pancreas and allowed to grow for 15 days. Mice were randomized to receive a combination of either secretagogue or saline and …
View article: ДОСВІД ВИКЛАДАННЯ ЗА ПРОГРАМОЮ ВООЗ mhGAP СТУДЕНТАМ ЗА СПЕЦІАЛЬНІСТЮ ФІЗИЧНА ТЕРАПІЯ В ДНІПРОВСЬКОМУ ДЕРЖАВНОМУ МЕДИЧНОМУ УНІВЕРСИТЕТІ
ДОСВІД ВИКЛАДАННЯ ЗА ПРОГРАМОЮ ВООЗ mhGAP СТУДЕНТАМ ЗА СПЕЦІАЛЬНІСТЮ ФІЗИЧНА ТЕРАПІЯ В ДНІПРОВСЬКОМУ ДЕРЖАВНОМУ МЕДИЧНОМУ УНІВЕРСИТЕТІ Open
View article: Table S1 from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment
Table S1 from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment Open
Table S1. Performance evaluation for SSZS-MRI versus RECIST. Diagnostic performance for early (1-3d) measurements by volumetric RECIST, and SSZS MRI show that SSZS MRI discriminates stable from progressive disease more accurately than RECI…
View article: Figure S1 from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment
Figure S1 from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment Open
Figure S1. Stimulated zinc secretion in PDAC mouse of FVB genetic background. A) Orthotopic PDAC cell implantation and imaging schedule. B) (left) Change in contrast to noise ratio (ΔCNR) after zinc probe and caerulein or saline for PDAC a…
View article: Data from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment
Data from Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to <i>KRAS</i><sup><i>G12D</i></sup> Inhibitor Treatment Open
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer, primarily because of late-stage diagnosis and limited treatment options. Zinc homeostasis is markedly dysregulated in PDAC, and this dysregulation can be probed by administ…
View article: Solid Pseudopapillary Neoplasm of the Pancreatic Body and Tail in a 14-Year-Old Female Patient: A Report of a Rare Case and Literature Review
Solid Pseudopapillary Neoplasm of the Pancreatic Body and Tail in a 14-Year-Old Female Patient: A Report of a Rare Case and Literature Review Open